VEGFA and in situ carcinoma: In addition, patients with MS + CIS with the highest levels of, for example, INFγ tended to have high levels of most of the other biomarkers, except granulocyte‐macrophage colony stimulating factor and VEGF, for which no differences were seen (data not shown).